Mobile Menu - OpenMobile Menu - Closed


Congressman Tom Marino

Representing the 10th District of Pennsylvania

Reps. Marino, Lewis Reintroduce Kidney Disease Bill

May 30, 2017
Press Release

Washington, D.C. -- Congressman Tom Marino (PA-10) and Congressman John Lewis (GA-05) reintroduced H.R. 2644, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. This bill is aimed at improving the lives of those suffering with kidney disease by identifying barriers for transplantation and improving donation rates.  It also allows individuals with kidney failure the ability to retain access to private insurance and promotes access to home dialysis treatments. Additionally, H.R. 2644 seeks to understand the progression of kidney disease and the treatment of kidney failure in minority populations and improve access to kidney disease treatment for those in underserved rural and urban areas.

Congressman Marino said the following regarding the introduction of this bill:

“I would like to thank my colleagues John Lewis and Peter Roskam for continuing to support our efforts to bring an end to Kidney disease and make access to breakthrough treatments easier to obtain for those suffering with this disease. Kidney disease has touched the lives of millions of American, including myself, and this bill is a step in the right direction to better understand the disease and find a cure.”

Congressman Lewis said the following:

“I am proud to introduce legislation with my colleague Tom Marino that has the power to ease the strain of kidney disease on patients and families.  Kidney disease is a debilitating medical condition that dramatically changes the lives of those who suffer from it.  Anything that we can do as the people’s representatives to help patients and families living with kidney disorders is our duty and obligation.  All the answers we need will not come from one legislative solution, but if we are persistent and consistent we can chip away at the obstacles this disease creates and one day find a cure.”